RxSight (RXST) Income towards Parent Company (2020 - 2026)

RxSight (RXST) has reported Income towards Parent Company for 7 consecutive years, with -$12.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income towards Parent Company fell 2.64% year-over-year to -$12.1 million; the trailing twelve-month figure through Jun 2026 stood at -$38.7 million (down 46.4% YoY), and the FY2025 full-year result was -$30.7 million, down 41.86% from the prior year.
• Income towards Parent Company grew to -$12.1 million in Q2 2026 per RXST's latest filing, from -$15.9 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $1.0 million in Q4 2023 and bottomed at -$17.6 million in Q1 2022.
• Historically, Income towards Parent Company has averaged -$9.5 million across 5 years, with a median of -$10.8 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Income towards Parent Company surged 165.78% in 2023, then plunged 588.06% in 2025.
• Over 5 years, Income towards Parent Company stood at -$1.6 million in 2022, then soared by 165.78% to $1.0 million in 2023, then slumped by 112.84% to -$134000.0 in 2024, then slumped by 588.06% to -$922000.0 in 2025, then sank by 1212.04% to -$12.1 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$12.1 million, -$15.9 million, and -$922000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.